191 related articles for article (PubMed ID: 31834617)
1. Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study.
Ohashi Y; Munesue M; Shimazaki J; Takamura E; Yokoi N; Watanabe H; Nomura A; Shimada F
Adv Ther; 2020 Feb; 37(2):707-717. PubMed ID: 31834617
[TBL] [Abstract][Full Text] [Related]
2. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.
Utsunomiya T; Kawahara A; Hanada K; Yoshida A
Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084
[TBL] [Abstract][Full Text] [Related]
3. Diquafosol ophthalmic solution for dry eye treatment.
Nakamura M; Imanaka T; Sakamoto A
Adv Ther; 2012 Jul; 29(7):579-89. PubMed ID: 22843206
[TBL] [Abstract][Full Text] [Related]
4. Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.
Keating GM
Drugs; 2015 May; 75(8):911-22. PubMed ID: 25968930
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye.
Koh S; Ikeda C; Takai Y; Watanabe H; Maeda N; Nishida K
Jpn J Ophthalmol; 2013 Sep; 57(5):440-6. PubMed ID: 23740285
[TBL] [Abstract][Full Text] [Related]
6. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
Shigeyasu C; Yamada M; Akune Y; Tsubota K
Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
[TBL] [Abstract][Full Text] [Related]
7. A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore.
Gong L; Sun X; Ma Z; Wang Q; Xu X; Chen X; Shao Y; Yao K; Tang L; Gu Y; Yuan H; Chua WH; Chuan JC; Tong L
Br J Ophthalmol; 2015 Jul; 99(7):903-8. PubMed ID: 25631485
[TBL] [Abstract][Full Text] [Related]
8. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
Yamane M; Ogawa Y; Fukui M; Kamoi M; Saijo-Ban Y; Yaguchi S; Mukai S; Kawakita T; Simmura S; Tsubota K
Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S25-32. PubMed ID: 25785527
[TBL] [Abstract][Full Text] [Related]
9. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
Hwang HS; Sung YM; Lee WS; Kim EC
Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
[TBL] [Abstract][Full Text] [Related]
10. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
[TBL] [Abstract][Full Text] [Related]
11. Effect of diquafosol ophthalmic solution on the optical quality of the eyes in patients with aqueous-deficient dry eye.
Koh S; Maeda N; Ikeda C; Oie Y; Soma T; Tsujikawa M; Watanabe H; Nishida K
Acta Ophthalmol; 2014 Dec; 92(8):e671-5. PubMed ID: 24863298
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Topical 3% Diquafosol Ophthalmic Solution for the Treatment of Multifactorial Dry Eye Disease: Meta-Analysis of Randomized Clinical Trials.
Nam K; Kim HJ; Yoo A
Ophthalmic Res; 2019; 61(4):188-198. PubMed ID: 30654362
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Topical Cyclosporine and Diquafosol Treatment in Dry Eye.
Yang JM; Choi W; Kim N; Yoon KC
Optom Vis Sci; 2015 Sep; 92(9):e296-302. PubMed ID: 26107023
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of diquafosol for real-world dry eye patients: a prospective, open-label, non-interventional, observational study.
Yamaguchi M; Nishijima T; Shimazaki J; Takamura E; Yokoi N; Watanabe H; Ohashi Y
Adv Ther; 2014 Nov; 31(11):1169-81. PubMed ID: 25376447
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis.
Toda I; Ide T; Fukumoto T; Ichihashi Y; Tsubota K
Am J Ophthalmol; 2014 Mar; 157(3):616-22.e1. PubMed ID: 24528935
[TBL] [Abstract][Full Text] [Related]
16. Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis.
Mori Y; Nejima R; Masuda A; Maruyama Y; Minami K; Miyata K; Amano S
Cornea; 2014 Jul; 33(7):659-62. PubMed ID: 24858017
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
[TBL] [Abstract][Full Text] [Related]
18. Effects of diquafosol tetrasodium administration on visual function in short break-up time dry eye.
Kaido M; Uchino M; Kojima T; Dogru M; Tsubota K
J Ocul Pharmacol Ther; 2013; 29(6):595-603. PubMed ID: 23537148
[TBL] [Abstract][Full Text] [Related]
19. Diquafosol tetrasodium: a novel dry eye therapy.
Nichols KK; Yerxa B; Kellerman DJ
Expert Opin Investig Drugs; 2004 Jan; 13(1):47-54. PubMed ID: 14680452
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial.
Park CH; Lee HK; Kim MK; Kim EC; Kim JY; Kim TI; Kim HK; Song JS; Yoon KC; Lee DH; Chung TY; Choi CY; Kim HS
BMC Ophthalmol; 2019 Jun; 19(1):131. PubMed ID: 31208393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
